PHILLIP FROST - 30 Sep 2025 SCHEDULE 13D/A Report for Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share (COCP)

Filing Manager
PHILLIP FROST
Reporting Manager
Phillip Frost, M.D.
Security
Cocrystal Pharma, Inc. Common Stock, par value $0.001 per share
Symbol
COCP
Shares outstanding
13,045,972 shares
Disclosed Ownership
1,382,873 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
02 Oct 2025, 18:29:15 UTC
Date of event
30 Sep 2025
Next filing
30 Oct 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Phillip Frost, M.D. 11% 1,382,873 1,382,873 0 /s/ Phillip Frost, M.D. Phillip Frost, M.D. 0000898860
Frost Gamma Investments Trust 10% 1,319,838 1,319,838 0 /s/ Phillip Frost, M.D. Phillip Frost, M.D., Trustee 0001380896